News
August 3, 2022

NuroKor coming to millions more people with Twenty20 Healthcare

William Ripley
Published on: 
August 3, 2022
Nurokor Team
Published on: 
August 3, 2022

NuroKor coming to millions more people with Twenty20 Healthcare

NuroKor Bioelectronics has signed a partnership with health and wellbeing product specialist Twenty20 Healthcare, offering the 20 million UK people affected by diabetes[1] and chronic pain,[2] access to cutting-edge, bioelectric treatment.

Headed by five medical device experts, Twenty20 is the latest UK stockist and distributor of NuroKor mibody and mitouch wearables devices, and specialises in supplying the latest, high-quality health and wellbeing products to community pharmacies and other healthcare providers.

Martin Lempriere, the company’s business development manager said: 

'With the changes in NHS Supply Chain, pandemic restrictions and the drive to increase and promote healthcare services in the community via local pharmacies, it is clear that there is a growing need for efficacious solutions that, with the help of pharmacists and other community healthcare professionals, support people to self-manage their health and care at home.

'We’re delighted to be partnering with NuroKor to include the evidence-based, state-of-the-art bioelectrical devices within our product portfolio of solutions that help to improve the lives of people right across the UK living with different health conditions.'

NuroKor founder and CEO Rick Rowan said: 

'We know how both pain and diabetes can significantly impact a person’s life, so I am delighted that our technology will be offered to an increasing number of patients seeking a safe, new way to help manage these types of conditions.

'We’ve seen an increasing number of pharmacies choosing to provide clinically-validated pain clinics for their patients, because many people are struggling with the negative side-effects of using opiates. Demand for the clinics has risen dramatically since the first lockdown and we’ve seen patients with a variety of conditions able to reduce their painkiller intake by 50-85% and some now aren’t taking painkillers at all. 

'With many GP practices switching to mainly online services, pharmacies have stepped up to provide more frontline services. There’s also an increased demand from people to treat themselves at home. Being proactive about meeting the needs of their communities, not only helps patients and relieves pressure on the NHS, but it also supports the future of pharmacies.'

You can find out more about NuroKor’s technologies and product here, and if you would like information on where to purchase or how to become a NuroKor partner, please contact us.

[1] https://www.diabetes.org.uk/professionals/position-statements-reports/statistics/diabetes-prevalence-2019 

[2]https://www.versusarthritis.org/about-arthritis/data-and-statistics/chronic-pain-in-england/#:~:text=Around%2015.5%20million%20people%20in,take%20part%20in%20daily%20activities